Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Baxter International (NY: BAX )

35.87 +0.17 (+0.48%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Baxter International

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference
From Baxter International Inc.
Via Business Wire
Where Baxter Intl Stands With Analysts
Within the last quarter, Baxter Intl (NYSE:BAX) has observed the following analyst ratings: 
Via Benzinga
Baxter to Host 2022 Investor Conference
From Baxter International Inc.
Via Business Wire
7 Defensive Dividend Healthcare Stocks to Buy Now
As market conditions remain rocky, adding high-quality healthcare stocks to your portfolio may be a great way to play defense. 
Via InvestorPlace
Analyst Ratings for Baxter Intl
Analysts have provided the following ratings for Baxter Intl (NYSE:BAX) within the last quarter: 
Via Benzinga
Recap: Baxter Intl Q1 Earnings
Baxter Intl (NYSE:BAX) reported its Q1 earnings results on Thursday, April 28, 2022 at 07:15 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: Baxter Intl Q4 Earnings
  Baxter Intl (NYSE:BAX) reported its Q4 earnings results on Thursday, February 17, 2022 at 07:15 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Baxter International's Return on Invested Capital Overview
Pulled from Benzinga Pro data, Baxter International (NYSE:BAX) showed a loss in earnings since Q4, totaling $73.00 million. Sales, on the other hand, increased by 5.49% to $3.71 billion during Q1. 
Via Benzinga
Baxter Increases Dividend and Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Baxter's FDA Review For Novum IQ Large Volume Pump Put On Hold, Lowers FY22 EPS Outlook
Via Benzinga
Baxter Reports First-Quarter 2022 Results
From Baxter International Inc.
Via Business Wire
Earnings Outlook For Baxter International
Baxter International (NYSE:BAX) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that Baxter... 
Via Benzinga
Earnings Scheduled For February 17, 2022
Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. 
Via Benzinga
Death Cross Looms Over Baxter Intl Investors
If history is any guide, there may be trouble ahead for shares of Baxter Intl (NYSE:BAX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock. 
Via Benzinga
Baxter Highlights New Data at SCCM Critical Care Congress Showing Hemodynamic Monitoring May Help Predict Patient Outcomes
From Baxter International Inc.
Via Business Wire
Baxter Announces U.S. FDA Clearance of ST Set Used to Help Treat Acute Kidney Injury Patients in the Hospital
From Baxter International Inc.
Via Business Wire
Why Savvy Investors Look For 'Ports In Storms' Like Agilent, Thermo Fisher And Others
Health remains a tricky investment area, but Evercore analysts say there are safe bets. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022
Upgrades 
Via Benzinga
10 Biggest Price Target Changes For Monday
Keybanc raised the price target on Block, Inc. (NYSE: SQ) from $175 to $180. Block shares rose 2.8% to $137.42 in pre-market trading. 
Via Benzinga
Ten Healthcare Companies With High Payout Ratio
The healthcare industry is among the biggest U.S. market segments in terms of market capitalization, but when it comes to dividend payouts, they rank very low. 
Via Talk Markets
Baxter to Host First-Quarter 2022 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
FDA Issues To Class I Recall To Baxter's Spectrum Infusion Pump
In December 2021, Baxter International Inc (NYSE: BAX) issued an urgent safety communication about an issue with some of its Spectrum infusion pumps. The FDA has... 
Via Benzinga
Boston Scientific Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
A Relative Strength Rating upgrade for Boston Scientific shows improving technical performance. 
Via Investor's Business Daily
Baxter Expands Cybersecurity Commitment, Joins Forces With U.S. Cybersecurity and Infrastructure Security Agency (CISA) Led Program
From Baxter International Inc.
Via Business Wire
Baxter to Present at the Raymond James 43rd Annual Institutional Investors Conference
From Baxter International Inc.
Via Business Wire
Analyst Ratings For Baxter Intl
Over the past 3 months, 6 analysts have published their opinion on Baxter Intl (NYSE:BAX) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
Baxter Clocks Better-Than-Expected Q4 Earnings, But FY22 Guidance Trail Street View
Baxter International Inc (NYSE: BAX) has posted Q4 revenue of $3.5 billion, beating the consensus of $3.35 billion, up 10% on a reported basis, 12% on a constant... 
Via Benzinga
Baxter International (BAX) Tops Q4 Earnings And Revenue Estimates
Baxter International came out with quarterly earnings of $1.04 per share. 
Via Talk Markets
Baxter Reports Fourth-Quarter and Full-Year 2021 Results
From Baxter International Inc.
Via Business Wire
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.